Cas no 1289388-02-8 ((4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE)
(4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE Chemical and Physical Properties
Names and Identifiers
-
- (4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE
- 4-chloro-5-methyl-N-propan-2-ylpyrimidin-2-amine
- (4-Chloro-5-methylpyrimidin-2-yl)isopropylamine
- (4-Chloro-5-methylpyrimidin-2-yl)-isopropylamine
- AB1010004
- AK-51933
- AM91605
- KB-01768
- DTXSID10693801
- 4-Chloro-N-isopropyl-5-methylpyrimidin-2-amine
- 4-Chloro-5-methyl-N-(propan-2-yl)pyrimidin-2-amine
- 4-chloro-N-isopropyl-5-methyl-pyrimidin-2-amine
- SB56332
- 1289388-02-8
- DA-17269
- AKOS015940360
-
- MDL: MFCD18837195
- Inchi: 1S/C8H12ClN3/c1-5(2)11-8-10-4-6(3)7(9)12-8/h4-5H,1-3H3,(H,10,11,12)
- InChI Key: OEHPPFIDFUHWAI-UHFFFAOYSA-N
- SMILES: ClC1=C(C)C=NC(=N1)NC(C)C
Computed Properties
- Exact Mass: 185.0719751g/mol
- Monoisotopic Mass: 185.0719751g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 12
- Rotatable Bond Count: 2
- Complexity: 140
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.6
- Topological Polar Surface Area: 37.8?2
Experimental Properties
- Density: 1.182
- Boiling Point: 287 oC
- Flash Point: 128 oC
(4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 088426-1g |
4-Chloro-5-methyl-pyrimidin-2-yl)-isopropyl-amine |
1289388-02-8 | 1g |
£503.00 | 2022-03-01 | ||
| Chemenu | CM167574-1g |
4-chloro-N-isopropyl-5-methylpyrimidin-2-amine |
1289388-02-8 | 95% | 1g |
$554 | 2021-08-05 | |
| Chemenu | CM167574-1g |
4-chloro-N-isopropyl-5-methylpyrimidin-2-amine |
1289388-02-8 | 95% | 1g |
$652 | 2024-08-02 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1778481-1g |
4-Chloro-N-isopropyl-5-methylpyrimidin-2-amine |
1289388-02-8 | 98% | 1g |
¥12391.00 | 2024-08-09 |
(4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE Related Literature
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
-
Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
Additional information on (4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE
Recent Advances in the Study of (4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE (CAS: 1289388-02-8)
The compound (4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE (CAS: 1289388-02-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This pyrimidine derivative is being explored for its potential applications in drug discovery, particularly as a key intermediate in the synthesis of novel therapeutic agents. Recent studies have focused on its structural properties, reactivity, and biological activity, shedding light on its promising role in medicinal chemistry.
One of the primary areas of interest is the compound's utility in the development of kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is often associated with various diseases, including cancer and inflammatory disorders. Researchers have synthesized and evaluated derivatives of (4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE to identify potent and selective kinase inhibitors. Preliminary results indicate that the compound's unique structural features, such as the chloro and methyl substituents on the pyrimidine ring, contribute to its ability to interact with specific kinase targets.
In addition to its potential as a kinase inhibitor scaffold, (4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE has also been investigated for its role in the synthesis of antiviral agents. Recent studies have demonstrated that modifications to the pyrimidine core can enhance the compound's antiviral activity, particularly against RNA viruses. These findings highlight the versatility of this chemical entity in addressing unmet medical needs.
The synthetic pathways for (4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE have also been optimized in recent research. Novel catalytic methods and green chemistry approaches have been employed to improve yield and reduce environmental impact. These advancements are crucial for scaling up production and ensuring the compound's availability for further preclinical and clinical studies.
Despite these promising developments, challenges remain in fully elucidating the compound's mechanism of action and optimizing its pharmacokinetic properties. Ongoing research aims to address these gaps through structure-activity relationship (SAR) studies and in vivo evaluations. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these findings into therapeutic applications.
In conclusion, (4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE (CAS: 1289388-02-8) represents a valuable scaffold in medicinal chemistry with diverse potential applications. Continued research into its derivatives and mechanisms will likely yield innovative treatments for a range of diseases, underscoring its importance in the field of chemical biology and drug discovery.
1289388-02-8 ((4-CHLORO-5-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)